World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
26109
World Ranking
14630
National Ranking
7401

Overview

Scott E. Eggener is affiliated with the University of Chicago in the United States. The scientist's research is primarily situated within the field of Medicine, with significant contributions across several subfields. These subfields include Pulmonary and Respiratory Medicine, Surgery, Oncology, Rheumatology, and Radiology, Nuclear Medicine and Imaging.

Eggener's main research topics focus largely on prostate cancer, incorporating areas such as treatment and research, diagnosis and treatment, and the broader spectrum of urologic and reproductive health conditions. Additional topics include testicular diseases and treatments, bladder and urothelial cancer treatments, sarcoma diagnosis and treatment, and health systems with economic evaluations related to quality of life.

Frequent publication venues for the scientist's work include:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • European Urology
  • Urologic Oncology Seminars and Original Investigations
  • International Journal of Radiation Oncology*Biology*Physics

Among the recent papers authored or co-authored by Eggener are:

  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management (2022), published in The Journal of Urology
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening (2023), published in The Journal of Urology
  • Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 (2020), published in Journal of Clinical Oncology
  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up (2022), published in The Journal of Urology
  • Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement (2020), published in American Journal of Transplantation

Eggener collaborates frequently with several researchers, including:

  • Aditya Bagrodia
  • Matthew R. Cooperberg
  • Siamak Daneshmand
  • Ragheed Saoud
  • Gladell P. Paner

Best Publications

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

    Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco

  • Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

    Scott E. Eggener;Peter T. Scardino;Patrick C. Walsh;Misop Han

  • POTENCY, CONTINENCE AND COMPLICATIONS IN 3,477 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES

    Shilajit D. Kundu;Kimberly A. Roehl;Scott E. Eggener;Jo Ann V. Antenor

  • Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.

    Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton

  • Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities

    Scott E. Eggener;Peter T. Scardino;Peter R. Carroll;Michael J. Zelefsky

  • The role of SPINK1 in ETS rearrangement-negative prostate cancers.

    Scott A. Tomlins;Daniel R. Rhodes;Jianjun Yu;Sooryanarayana Varambally

  • Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR

    Andrew B. Rosenkrantz;Sadhna Verma;Peter Choyke;Steven C. Eberhardt

  • Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.

    Ryan K. Berglund;Timothy A. Masterson;Kinjal C. Vora;Scott E. Eggener

  • Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline

    Antonio Finelli;Nofisat Ismaila;Bill Bro;Jeremy Durack

  • New and Established Technology in Focal Ablation of the Prostate: A Systematic Review

    Massimo Valerio;Massimo Valerio;Massimo Valerio;Yannick Cerantola;Scott E. Eggener;Herbert Lepor

  • Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.

    Scott E. Eggener;Ofer Yossepowitch;Joseph A. Pettus;Mark E. Snyder

  • Positive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes

    Ofer Yossepowitch;R. Houston Thompson;Bradley C. Leibovich;Scott E. Eggener

  • Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis

    Aytekin Oto;Cheng Yang;Arda Kayhan;Maria Tretiakova

  • Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.

    Jamie Messer;Shahrokh F. Shariat;James C. Brien;Michael P. Herman

  • Increasing incidence of metastatic prostate cancer in the United States (2004–2013)

    A B Weiner;R S Matulewicz;S E Eggener;E M Schaeffer

  • Radical Prostatectomy for Clinically Localized, High Risk Prostate Cancer: Critical Analysis of Risk Assessment Methods

    Ofer Yossepowitch;Scott E. Eggener;Fernando J. Bianco;Brett S. Carver

  • Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans.

    N M Dietz;J M Rivera;S E Eggener;R T Fix

  • Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus Meeting

    Ian A. Donaldson;Ian A. Donaldson;Roberto Alonzi;Dean Barratt;Eric Barret

  • Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma

    James C. Brien;Shahrokh If. Shariat;Michael P. Herman;Casey K. Ng

  • Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.

    Yahui Peng;Yulei Jiang;Cheng Yang;Jeremy Bancroft Brown

Frequent Co-Authors

Peter T. Scardino
Peter T. Scardino Memorial Sloan Kettering Cancer Center
James A. Eastham
James A. Eastham Memorial Sloan Kettering Cancer Center
Jay D. Raman
Jay D. Raman Penn State Milton S. Hershey Medical Center
Paul Russo
Paul Russo Memorial Sloan Kettering Cancer Center
William J. Catalona
William J. Catalona Northwestern University
Peter A. Pinto
Peter A. Pinto National Institutes of Health
Eric A. Klein
Eric A. Klein Cleveland Clinic
Yair Lotan
Yair Lotan The University of Texas Southwestern Medical Center
Mark Emberton
Mark Emberton University College London
Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a variety of rewarding online healthcare degrees and professional paths. For those interested in leadership, the top cahme-accredited mha programs provide flexible options to earn a Master of Healthcare Administration. These programs are highly reputable and ideal for those looking to advance into management or executive roles.

Nursing professionals aiming to upgrade their qualifications can consider the online rn to bsn no clinicals degrees. These programs allow registered nurses to earn a Bachelor of Science in Nursing without on-site clinical requirements, making it easier for working nurses to keep up with the demands of their jobs.

For nurses interested in the highest level of clinical practice, there are short dnp programs available online. These accelerated programs enable nurses to quickly earn a Doctor of Nursing Practice and take on advanced practice or leadership roles. If finding a manageable workload is a priority, candidates can explore the easiest dnp program online resources to match their personal and professional needs.

Best Scientists Citing Scott E. Eggener

Trending Scientists